Comparing two assays for clinical genomic profiling: the devil is in the data

por Squillace, Rachel M, Frampton, Garrett M, Stephens, Phil J, Ross, Jeffrey S, Miller, Vincent A
Publicado 2015

Unique Genomic Landscape of High-Grade Neuroendocrine Cervical Carcinoma: Implications for Rethinking Current Treatment Paradigms

por Eskander, Ramez N., Elvin, Julia, Gay, Laurie, Ross, Jeffrey S., Miller, Vincent A., Kurzrock, Razelle
Publicado 2020

Phosphatidylinositol 3‐kinase pathway genomic alterations in 60,991 diverse solid tumors informs targeted therapy opportunities

por Millis, Sherri Z., Jardim, Denis L., Albacker, Lee, Ross, Jeffrey S., Miller, Vincent A., Ali, Siraj M., Kurzrock, Razelle
Publicado 2018

Estimated Cost of Anticancer Therapy Directed by Comprehensive Genomic Profiling in a Single-Center Study

por Chawla, Anita, Janku, Filip, Wheler, Jennifer J., Miller, Vincent A., Ryan, Jason, Anhorn, Rachel, Zhou, Zhou, Signorovitch, James
Publicado 2018

Comprehensive genomic profiling identifies novel NTRK fusions in neuroendocrine tumors

por Sigal, Darren S., Bhangoo, Munveer S., Hermel, Jonathan A., Pavlick, Dean C., Frampton, Garrett, Miller, Vincent A., Ross, Jeffrey S., Ali, Siraj M.
Publicado 2018

Attrition of Patients on a Precision Oncology Trial: Analysis of the I‐PREDICT Experience

por Bohan, Sandy S., Sicklick, Jason K., Kato, Shumei, Okamura, Ryosuke, Miller, Vincent A., Leyland‐Jones, Brian, Lippman, Scott M., Kurzrock, Razelle
Publicado 2020

Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain

por Pao, William, Miller, Vincent A, Politi, Katerina A, Riely, Gregory J, Somwar, Romel, Zakowski, Maureen F, Kris, Mark G, Varmus, Harold
Publicado 2005

Detection of an ALK Fusion in Colorectal Carcinoma by Hybrid Capture‐Based Assay of Circulating Tumor DNA

por Lai, Andrea Z., Schrock, Alexa B., Erlich, Rachel L., Ross, Jeffrey S., Miller, Vincent A., Yakirevich, Evgeny, Ali, Siraj M., Braiteh, Fadi
Publicado 2017

Identifying Opportunities and Challenges for Patients With Sarcoma as a Result of Comprehensive Genomic Profiling of Sarcoma Specimens

por Hay, Margaret A., Severson, Eric A., Miller, Vincent A., Liebner, David A., Vergilio, Jo-Anne, Millis, Sherri Z., Chen, James L.
Publicado 2020

Response to rapamycin analogs but not PD-1 inhibitors in PTEN-mutated metastatic non-small-cell lung cancer with high tumor mutational burden

por Parikh, Ankur R, Ali, Siraj M, Schrock, Alexa B, Albacker, Lee A, Miller, Vincent A, Stephens, Phil J, Crilley, Pamela, Markman, Maurie
Publicado 2018

Exceptional Response to Everolimus in a Patient with Metastatic Castrate-Resistant Prostate Cancer Harboring a PTEN Inactivating Mutation

por Kmak, Jamie A., Agarwal, Nikita, He, Yuting, Heilmann, Andreas M., Miller, Vincent A., Ross, Jeffrey S., Pal, Sumanta Kumar, Ali, Siraj M., Kilari, Deepak
Publicado 2020

Extended Antitumor Response of a BRAF V600E Papillary Thyroid Carcinoma to Vemurafenib

por Ali, Siraj M., He, Je, Carson, Wade, Stephens, Phil J., Fiorillo, Joseph, Lipson, Doron, Palmer, Gary A., Ross, Jeffrey S., Miller, Vincent A., Sharman, Jeffrey
Publicado 2014

A Case of Metastatic Atypical Neuroendocrine Tumor with ALK Translocation and Diffuse Brain Metastases

por Wang, Victoria E., Young, Lauren, Ali, Siraj, Miller, Vincent A., Urisman, Anatoly, Wolfe, John, Bivona, Trever G., Damato, Bertil, Fogh, Shannon, Bergsland, Emily K.
Publicado 2017

Targeted therapy by combined inhibition of the RAF and mTOR kinases in malignant spindle cell neoplasm harboring the KIAA1549-BRAF fusion protein

por Subbiah, Vivek, Westin, Shannon N, Wang, Kai, Araujo, Dejka, Wang, Wei-Lien, Miller, Vincent A, Ross, Jeffrey S, Stephens, Phillip J, Palmer, Gary A, Ali, Siraj M
Publicado 2014

KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib

por Pao, William, Wang, Theresa Y, Riely, Gregory J, Miller, Vincent A, Pan, Qiulu, Ladanyi, Marc, Zakowski, Maureen F, Heelan, Robert T, Kris, Mark G, Varmus, Harold E
Publicado 2005

Exceptional durable response to everolimus in a patient with biphenotypic breast cancer harboring an STK11 variant

por Parachoniak, Christine A., Rankin, Andrew, Gaffney, Bernadette, Hartmaier, Ryan, Spritz, Dan, Erlich, Rachel L., Miller, Vincent A., Morosini, Deborah, Stephens, Phil, Ross, Jeffrey S., Keech, John, Chmielecki, Juliann
Publicado 2017

A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal

por Sun, James X., He, Yuting, Sanford, Eric, Montesion, Meagan, Frampton, Garrett M., Vignot, Stéphane, Soria, Jean-Charles, Ross, Jeffrey S., Miller, Vincent A., Stephens, Phil J., Lipson, Doron, Yelensky, Roman
Publicado 2018

Identification and characterization of RET fusions in advanced colorectal cancer

por Le Rolle, Anne-France, Klempner, Samuel J., Garrett, Christopher R., Seery, Tara, Sanford, Eric M., Balasubramanian, Sohail, Ross, Jeffrey S., Stephens, Philip J., Miller, Vincent A., Ali, Siraj M., Chiu, Vi K.
Publicado 2015

A Poorly Differentiated Malignant Neoplasm Lacking Lung Markers Harbors an EML4-ALK Rearrangement and Responds to Crizotinib

por Chung, Jon H., Ali, Siraj M., Davis, Jenni, Robstad, Karl, McNally, Richard, Gay, Laurie M., Erlich, Rachel L., Palma, Norma A., Stephens, Phil J., Miller, Vincent A., Cutugno, Alfonso, Ross, Jeffrey S.
Publicado 2014

FGFR2‐Altered Gastroesophageal Adenocarcinomas Are an Uncommon Clinicopathologic Entity with a Distinct Genomic Landscape

por Klempner, Samuel J., Madison, Russell, Pujara, Vivek, Ross, Jeffrey S., Miller, Vincent A., Ali, Siraj M., Schrock, Alexa B., Kim, Seung Tae, Maron, Steven B., Dayyani, Farshid, Catenacci, Daniel V.T., Lee, Jeeyun, Chao, Joseph
Publicado 2019